Attovia director Angie You files initial ownership
Attovia Therapeutics, Inc. director Angie You reported initial equity holdings.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Attovia Therapeutics, Inc. director Angie You reported initial equity holdings. The filing lists 52,852 shares of Common Stock held directly and a stock option for 19,913 shares of Common Stock at an exercise price of $4.9237 per share, expiring on May 17, 2035. Footnotes describe three-year vesting schedules, with portions of the options vesting annually through July 29, 2027 and May 18, 2028, conditioned on continued service.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
You Angie
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| Holding | Common Stock F1 | -- | -- | -- |
Holdings:
Stock Option (Right to Buy) — 19,913 contracts (Direct);
Common Stock — 52,852 shares (Direct)
Footnotes (2)
- F1. The option vests over a three-year period. The vesting schedule is as follows: 33% vested on June 29, 2025, an additional 33% vested on June 29, 2026, and the final 33% shall vest on July 29, 2027, subject to reporting person's continued service to the Issuer on each vesting date.
- F2. The option vests over a three-year period. The vesting schedule is as follows: 33% vested on May 18, 2026, an additional 33% shall vest on May 18, 2027, and the final 33% shall vest on May 18, 2028, subject to the reporting person's continued service to the Issuer on each vesting date.
Key Figures
Common Stock held: 52,852 shares
Option underlying shares: 19,913 shares
Option exercise price: $4.9237 per share
+3 more
6 metrics
Common Stock held
52,852 shares
Directly owned Common Stock reported as of 2026-08-04
Option underlying shares
19,913 shares
Underlying Common Stock for Stock Option (Right to Buy)
Option exercise price
$4.9237 per share
Exercise price of Stock Option (Right to Buy)
Option expiration
May 17, 2035
Expiration date of reported stock option
First vesting schedule
33% on June 29, 2025, 2026, July 29, 2027
Three-year vesting for one option grant, service-based
Second vesting schedule
33% on May 18, 2026, 2027, 2028
Three-year vesting for another option grant, service-based
Key Terms
Stock Option (Right to Buy), Common Stock, vesting schedule, exercise price
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vesting schedule financial
"The option vests over a three-year period. The vesting schedule is as follows"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
exercise price financial
"conversion_or_exercise_price: 4.9237"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 3 filing by Angie You for ATTO report?
The Form 3 for Attovia Therapeutics (ATTO) reports Angie You’s initial ownership, including 52,852 Common Stock shares and a stock option for 19,913 shares of Common Stock, plus associated vesting schedules.
What stock options does Angie You report in the ATTO Form 3?
Angie You reports a Stock Option (Right to Buy) covering 19,913 underlying Common Stock shares with an exercise price of $4.9237 per share and an expiration date of May 17, 2035.
What are the vesting terms of Angie You’s options in Attovia Therapeutics (ATTO)?
The options vest over three-year periods. One grant vests 33% each on June 29, 2025, 2026, and July 29, 2027. Another vests 33% on May 18, 2026, then May 18, 2027, and May 18, 2028, contingent on continued service.
Does the ATTO Form 3 show any recent stock purchases or sales by Angie You?
The Form 3 lists holdings and option positions only and shows no buy or sell transactions. It serves as an initial ownership report rather than a record of trading activity.
AI-generated analysis. How Rhea-AI works. Not financial advice.
